Avalon GloboCare (CHGA) Stock Price, News & Analysis

Company Overview

Avalon GloboCare Corp. is a life sciences company focused on developing cell-based technologies and precision medicine applications. Its work has included regenerative medicine, cancer diagnostics, and therapeutic platforms designed to support the development of personalized healthcare treatments.

The company has also pursued technologies involving cellular processing, biomanufacturing, and related laboratory services. Avalon GloboCare’s activities have included collaborations and development programs intended to translate emerging cell and molecular science into clinical and commercial applications.

Avalon GloboCare was established in the mid-2010s and has been headquartered in Freehold, New Jersey. Public company materials have identified David Jin as a senior executive and have described the company as serving the biotechnology and healthcare markets, although specific programs, operations, and leadership arrangements may change over time.

Key Stats

• Today's Range: $1.88 to $3.62
• 50-Day Range: $1.86 to $5.58
• 52-Week Range: $1.80 to $49.20
• Volume: 32.42 million shs
• Average Volume: 48,465 shs
• Market Capitalization: $2.69 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

Avalon GloboCare Stock Analysis - MarketRank™

Avalon GloboCare scored higher than 17% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.7 / 5
• Analyst Rating: Sell

Consensus Rating

Avalon GloboCare has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Avalon GloboCare has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Avalon GloboCare is -0.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Avalon GloboCare is -0.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

3.91% of the float of Avalon GloboCare has been sold short.

Short Interest Ratio / Days to Cover

Avalon GloboCare has a short interest ratio ("days to cover") of 0.68, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Avalon GloboCare has recently decreased by 51.77%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Avalon GloboCare does not currently pay a dividend.

Dividend Growth

Avalon GloboCare does not have a long track record of dividend growth.

News and Social Media

• Score: 2.9 / 5
• News Sentiment: 0.71

News Sentiment

Avalon GloboCare has a news sentiment score of 0.71. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Technology companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for Avalon GloboCare this week, compared to 2 articles on an average week.

Search Interest

Only 2 people have searched for CHGA on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.

MarketBeat Follows

2 people have added Avalon GloboCare to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Avalon GloboCare insiders have not sold or bought any company stock.

Percentage Held by Insiders

24.19% of the stock of Avalon GloboCare is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

1.42% of the stock of Avalon GloboCare is held by institutions.

Company Calendar

• Last Earnings: 8/14/2026
• Today: 9/30/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Technology
• Industry: Software
• Sub-Industry: Application Software
• Current Symbol: NASDAQ:CHGA
• Previous Symbol: NASDAQ:ALBT
• CIK: 1630212
• Web: www.avalon-globocare.com
• Phone: (732) 780-4400
• Fax: 732-780-5600
• Employees: 5
• Year Founded: 2014

Profitability

• EPS (Trailing Twelve Months): ($13.80)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$18.26 million
• Net Margins: N/A
• Pretax Margin: -5,608.29%
• Return on Equity: N/A
• Return on Assets: -53.69%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.11
• Quick Ratio: 0.11

Sales & Book Value

• Annual Sales: $1.26 million
• Price / Sales: 2.13
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($75.46) per share
• Price / Book: -0.03

Miscellaneous

• Outstanding Shares: 1,120,000
• Free Float: 849,000
• Market Cap: $2.69 million
• Optionable: Not Optionable
• Beta: -0.05